Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy

Bioconjugate Chemistry

Volumn 23, Issue 1, 2012, Pages 84-96

  Guaragna, Annalisa ^a   Chiaviello, Angela ^a   Paolella, Concetta ^a   DAlonzo, Daniele ^a   Palumbo, Giuseppe ^a   Palumbo, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; TARGETED DRUG DELIVERY; TUMORS;

ANTI-TUMORS; CYTOTOXIC AGENTS; DELIVERY SYSTEMS; DRUG-DELIVERY SYSTEMS; FOLATE RECEPTOR; FOLATES; MALIGNANT CELLS; RECEPTOR CELLS; TARGETED CHEMOTHERAPY; TUMOR SITE;

CHEMOTHERAPY;

CHLORAMBUCIL; FOLIC ACID;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE;

EID: 84855938089     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200410d     Document Type: Article

References (55)

1. Kratz, F., Müller, I. A., Ryppa, C., and Warnecke, A. (2008) Prodrug strategies in anticancer chemotherapy ChemMedChem 3, 20-53
2. Allen, T. M. (2002) Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2, 750-763 (Pubitemid 37328910)
3. Russell-jones, G., Mctavish, K., Mcewan, J., Rice, J., and Nowotnik, D. (2004) Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumors J. Inorg. Biochem. 28, 1625-1633 (Pubitemid 39349188)
4. Gupta, Y., Kohli, D. V., and Jain, S. K. (2008) Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents Crit. Rev. Ther. Drug Carrier Syst. 25, 347-379 (Pubitemid 351847206)
5. Ojima, I. (2008) Guided molecular missiles for tumor-targeting chemotherapy - case studies using the second-generation taxoids as warheads Acc. Chem. Res. 41, 108-119
6. Chen, S., Zhao, X., Chen, J., Chen, J., Kuznetsova, L., Wong, S. S., and Ojima, I. (2010) Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release Bioconjugate Chem. 21, 979-987
7. Bareford, L. M. and Swaan, P. W. (2007) Endocytic mechanisms for targeted drug delivery Adv. Drug Delivery Rev. 59, 748-758 (Pubitemid 47320813)
8. Xia, W. and Low, P. S. (2010) Folate-targeted therapies for cancer J. Med. Chem. 53, 6811-6824
9. Low, P. S. and Kularatne, S. A. (2009) Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 13, 256-262
10. Low, P. S., Henne, W. A., and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases Acc. Chem. Res. 41, 120-129
11. Sabharanjak, S. and Mayor, S. (2004) Folate receptor endocytosis and trafficking Adv. Drug Delivery Rev. 56, 1099-1109 (Pubitemid 38496510)
12. Elnakat, H. and Ratnam, M. (2004) Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy Adv. Drug Delivery Rev. 56, 1067-1084 (Pubitemid 38496508)
13. Wang, S. and Low, P. S. (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells J. Controlled Release 53, 39-48 (Pubitemid 28218688)
14. Reddy, J. A., Westrick, E., Santhapuram, H. K. R., Howard, S. J., Miller, M. L., Vetzel, M., Vlahov, I., Chari, R. V. J., Goldmacher, V. S., and Leamon, C. P. (2007) Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate Cancer Res. 67, 6376-6382 (Pubitemid 47037521)
15. Leamon, C. P., Reddy, J. A., Vlahov, I. R., Westrick, E., Dawson, A., Dorton, R., Vetzel, M., Santhapuram, H. K., and Wang, Y. (2007) Preclinical antitumor activity of a novel folate-targeted dual drug conjugate Mol. Pharmaceutics 4, 659-667 (Pubitemid 350004265)
16. Li, J., Sausville, E. A., Klein, P. J., Morgenstern, D., Leamon, C. P., Messmann, R. A., and LoRusso, P. (2009) Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients J. Clin. Pharmacol. 49, 1467-1476
17. Leamon, C. P., Reddy, J. A., Klein, P. J., Vlahov, I. R., Dorton, R., Bloomfield, A., Nelson, M., Westrick, E., Parker, N., Bruna, K., Vetzel, M., Gehrke, M., Nicoson, J. S., Messmann, R. A., LoRusso, P. M., and Sausville, E. A. (2011) Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications J. Pharmacol. Exp. Ther. 336, 336-343
18. Vlahov, I. R., You, F., Santhapuram, H. K., Wang, Y., Vaughn, J. F., Hahn, S. J., Kleindl, P. J., Fan, M., and Leamon, C. P. (2011) Design and regioselective synthesis of a new generation of targeted therapeutics. Part 3: Folate conjugates of aminopterin hydrazide for the treatment of inflammation Bioorg. Med. Chem. Lett. 21, 1202-1205
19. Vlahov, I. R., Santhapuram, H. K., You, F., Wang, Y., Kleindl, P. J., Hahn, S. J., Vaughn, J. F., Reno, D. S., and Leamon, C. P. (2010) Carbohydrate-based synthetic approach to control toxicity profiles of folate-drug conjugates J. Org. Chem. 75, 3685-3691
20. Sordet, O., Rébé, C., Leroy, I., Bruey, J. M., Garrido, C., Miguet, C., Lizard, G., Plenchette, S., Corcos, L., and Solary, E. (2002) S pecific involvement of caspases in the differentiation of monocytes into macrophages Blood 100, 4446-4453 (Pubitemid 35429684)
21. Sun, J., Wang, L., Waring, M. A., Wang, C., Woodman, K. K., and Sheil, A. G. (1997) Simple and reliable methods to assess hepatocyte viability in bioartificial liver support system matrices Artif. Organs 21, 408-413 (Pubitemid 27238861)
22. Aloyz, R., Grzywacz, K., Xu, Z.-Y., Loignon, M, Alaoui-Jamali, M. A., and Panasci, L (2004) Imatinib sensitizes CLL lymphocytes to chlorambucil Leukemia 18, 409-414 (Pubitemid 38425852)
23. Crescenzi, E., Chiaviello, A., Canti, G., Reddi, E., Veneziani, B. M., and Palumbo, G. (2006) Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299) Mol. Cancer Ther. 5, 776-785
24. Laemmli, U. K. (1971) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227, 680-685
25. Guaragna, A., Amoresano, A., Pinto, V., Monti, G., Mastrobuoni, G., Marino, G., and Palumbo, G. (2008) Synthesis and proteomic activity evaluation of a new isotope-coded affinity tagging (ICAT) reagent Bioconjugate Chem. 19, 1095-1104 (Pubitemid 351748319)
26. Dhar, S., Liu, Z., Thomale, J., Dai, H., and Lippard, S. J. (2008) Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J. Am. Chem. Soc. 130, 11467-11476
27. Seebach, D. and Gardiner, J. (2008) Beta-peptidic peptidomimetics Acc. Chem. Res. 41, 1366-1375
28. Rajski, S. R. and Williams, R. M. (1998) DNA cross-linking agents as antitumor drugs Chem. Rev. 98, 2723-2796
29. Amrein, L, Loignon, M., Goulet, A. C., Dunn, M., Jean-Claude, B., Aloyz, R., and Panasci, L. (2007) Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase J. Pharmacol. Exp. Ther. 321, 848-855 (Pubitemid 46762695)
30. Sierra, E. E. and Goldman, I. D. (1999) Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates Semin. Oncol. 26, 11-23 (Pubitemid 29218023)
31. Matherly, L. H. and Goldman, D. I. (2003) Membrane transport of folates Vitam. Horm. 66, 403-456 (Pubitemid 137640823)
32. Branda, R. F., ONeill, J. P., Brooks, E. M., Trombley, L. M., and Nicklas, J. A. (2001) The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status Mutat. Res. 473, 51-71 (Pubitemid 32126542)
33. Antony, A. C. (1996) Folate receptors Annu. Rev. Nutr. 16, 501-521 (Pubitemid 26286863)
34. Antohe, F., Radulescu., L., Puchianu, E., Kennedy, M. D., Low, P. S., and Simionescu, M. (2005) Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia Cell Tissue Res. 320, 277-285 (Pubitemid 40684754)
35. Roy, E. J., Gawlick, U., Orr, B. A., and Kranz, D. M. (2004) Folate-mediated targeting of T cells to tumors Adv. Drug Delivery Rev. 56, 1219-1231
36. Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J., and Boothman, D. A. (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein J. Biol. Chem. 278, 11590-11600 (Pubitemid 36792721)
37. Johnston, J. B., Daeninck, P., Verburg, L., Lee, K., Williams, G., Israels, L. G., Mowat, M. R., and Begleiter, A. (1997) P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia Leuk. Lymphoma 5-6, 435-449 (Pubitemid 27477770)
38. Twaites, B., de las Heras Alarcón, C., and Alexander, C. (2005) Synthetic polymers as drugs and therapeutics J. Mater. Chem. 15, 441-455 (Pubitemid 40159875)
39. Duncan, R. (2006) Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 6, 688-701 (Pubitemid 44286001)
40. Spiteller, P. and Von Nussbaum, F. (2004) b-Amino acids in nature. Highlights in Bioorganic Chemistry: Methods and Applications (Schmuck, C. and Wennemers, H., Eds.) pp 19-91, Wiley-VCH, Weinheim.
41. Hook, D. F., Gessier, F., Noti, C., Kast, P., and Seebach, D. (2004) Probing the proteolytic stability of b-peptides containing a-fluoro- and a-hydroxy-b-amino acids ChemBioChem 5, 691-706 and references therein cited. (Pubitemid 39257092)
42. 3/α- tetrapeptide in rats Chem. Biodivers. 1, 1812-1828
43. 14C-labeled β-nonapeptide in rats - in vitro and in vivo pharmacokinetic studies Biopharm. Drug Dispos. 23, 251-262
44. 3-amino acids Synthesis 23, 4013-4016 and references therein cited. (Pubitemid 44951791)
45. Panasci, L., Paiement, J. P., Christodoulopoulos, G., Belenkov, A., Malapetsa, A., and Aloyz, R. (2001) Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair Clin. Cancer Res. 7, 454-461 (Pubitemid 32707964)
46. Reux, B., Weber, V., Galmier, M. J., Borel, M., Madesclaire, M., Madelmont, J. C., and Debiton, E. (2008) Synthesis and cytotoxic properties of new fluorodeoxyglucose-coupled chlorambucil derivatives Bioorg. Med. Chem. 16, 5004-5020 (Pubitemid 351635770)
47. Keating, M. J., Kantarjian, H., Talpaz, M., Redman, J., Koller, C., Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E. J., and McCredie, K. B. (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood 74, 19-25 (Pubitemid 19187405)
48. Keating, M. J., Kantarjian, H., OBrien, S., Koller, C., Talpaz, M., Schachner, J., Childs, C. C., Freireich, E. J., and McCredie, K. B. (1991) Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia J. Clin. Oncol. 9, 44-49
49. Eichhorst, B. F., Busch, R., Stilgenbauer, S., Stauch, M., Bergmann, M. A., Ritgen, M., Kranzhöfer, N., Rohrberg, R., Söling, U., Burkhard, O., Westermann, A., Goede, V., Schweighofer, C. D., Fischer, K., Fink, A.-M., Wendtner, C. M., Brittinger, G., Döhner, H., Emmerich, B., and Hallek, M., the German CLL Study Group (GCLLSG) (2009) First-line therapy with fludarabine compared with chlorambucil does not lymphocytic result in a major benefit for elderly patients with advanced chronic leukemia. Blood 114, 3382-3391.
50. Dreyling, M., Polliack, A., and Tadmor, T. (2011) Chlorambucil in indolent mantle cell lymphoma-just another old drug for a new disease? Leuk. Lymphoma 52, 351-352
51. Chiappella, A., Ciochetto, C., Orsucci, L., and Vitolo, U. (2011) Update in Indolent Non-Hodgkin Lymphoma (NHL): Paradigm for Waldenströms Macroglobulinemia (WM) Clin. Lymphoma Myeloma Leuk. 11, 149-151
52. Goede, V. and Hallek, M. (2011) Optimal pharmacotherapeutic management of chronic lymphocytic leukaemia: considerations in the elderly Drugs Aging 28, 163-176
53. Pedersen, P. J., Christensen, M. S., Ruysschaert, T., Linderoth, L., Andresen, T. L., Melander, F., Mouritsen, O. G., Madsen, R., and Clausen, M. H. (2009) Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs J. Med. Chem. 52, 3408-3415 and references therein cited.
54. Bielawski, K. and Bielawska, A. (2008) Small-molecule based delivery systems for alkylating antineoplastic compounds ChemMedChem 3, 536-542
55. Salmaso, S., Bersani, S., Semenzato, A., and Caliceti, P. (2007) New cyclodextrin bioconjugates for active tumour targeting J. Drug Targeting 15, 379-390 (Pubitemid 47073053)